SARS-CoV-2 antibody response after COVID-19 in patients with rheumatic disease

Ann Rheum Dis. 2021 Jun;80(6):817-819. doi: 10.1136/annrheumdis-2020-219808. Epub 2021 Jan 12.
No abstract available

Keywords: COVID-19; autoimmune diseases; epidemiology.

Publication types

  • Letter
  • Research Support, Non-U.S. Gov't
  • Research Support, N.I.H., Extramural

MeSH terms

  • Antibodies, Viral
  • Antibody Formation
  • Antirheumatic Agents* / therapeutic use
  • Autoimmune Diseases*
  • COVID-19*
  • Humans
  • Rheumatic Diseases* / complications
  • Rheumatic Diseases* / drug therapy
  • SARS-CoV-2

Substances

  • Antibodies, Viral
  • Antirheumatic Agents